Addressing drug safety of maternal therapy during breastfeeding using <scp>physiologically‐based pharmacokinetic</scp> modeling-Reference-Cited by-同舟云学术

Addressing drug safety of maternal therapy during breastfeeding using physiologically‐based pharmacokinetic modeling

Published:2022-04-28 Issue:5 Volume:11 Page:535-539
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Pan Xian¹^ORCID,Rowland Yeo Karen¹^ORCID

Affiliation:

1. Simcyp Division Certara UK Limited Sheffield UK

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12802

Reference10 articles.

1. Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically‐based pharmacokinetic model

2. Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations

3. USFood and Drug Administration (FDA).Clinical lactation studies: considerations for study design. Guidance for industry. Draft guidance.https://www.fda.gov/media/124749/download(2019).

4. Clinical lactation studies and the role of pharmacokinetic modeling and simulation in predicting drug exposures in breastfed infants

5. Models and methods for predicting drug transfer into human milk

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EMA perspective on the value of model‐informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding;CPT: Pharmacometrics & Systems Pharmacology;2024-08-13

2. Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example;CPT: Pharmacometrics & Systems Pharmacology;2023-12-12

3. Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy;Pharmaceutics;2023-10-13

4. Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for Sotalol;The Journal of Clinical Pharmacology;2023-06

5. Quantitative approaches to drug safety: The 2022 PSP special issue;CPT: Pharmacometrics & Systems Pharmacology;2022-05